Search Results - "Storrer, CE"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Clinical Trial Results of a HER2/neu (E75) Vaccine to Prevent Recurrence in High-Risk Breast Cancer Patients by PEOPLES, George E, GURNEY, Jennifer M, HUEMAN, Matthew T, WOLL, Mike M, RYAN, Gayle B, STORRER, Catherine E, FISHER, Christine, SHRIVER, Craig D, IOANNIDES, Constantin G, PONNIAH, Sathibalan

    Published in Journal of clinical oncology (20-10-2005)
    “…E75 is an immunogenic peptide from the HER2/neu protein that is highly expressed in breast cancer. We are conducting a clinical trial of an E75 +…”
    Get full text
    Journal Article
  2. 2

    Spontaneous formation of germinal centers in autoimmune mice by Luzina, Irina G., Atamas, Sergei P., Storrer, Catherine E., daSilva, Ludmila C., Kelsoe, Garnett, Papadimitriou, John C., Handwerger, Barry S.

    Published in Journal of leukocyte biology (01-10-2001)
    “…The mechanisms of autoantibody production are not well understood. Germinal centers (GC) may be important sites of immune disregulation in autoimmune diseases…”
    Get full text
    Journal Article
  3. 3

    Vaccination with a HER2/ neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer by Mittendorf, Elizabeth A., Gurney, Jennifer M., Storrer, Catherine E., Shriver, Craig D., Ponniah, Sathibalan, Peoples, George E.

    Published in Surgery (01-03-2006)
    “…We are conducting clinical vaccine trials with the HER2/ neu peptide, E75, in patients with breast cancer. The purpose of this study was to demonstrate clonal…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Evaluation of the CD107 cytotoxicity assay for the detection of cytolytic CD8+ cells recognizing HER2/neu vaccine peptides by MITTENDORF, Elizabeth A, STORRER, Catherine E, SHRIVER, Craig D, PONNIAH, Sathibalan, PEOPLES, George E

    Published in Breast cancer research and treatment (01-07-2005)
    “…The recently reported FACS-based CD107 assay has been used in human HIV and CMV antigen models as well as in the ex vivo analysis of tumor cytolytic T cells in…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Assessing serum cytokine profiles in breast cancer patients receiving a HER2/neu vaccine using Luminex registered technology by Dehqanzada, Z A, Storrer, CE, Hueman, M T, Foley, R J, Harris, KA, Jama, Y H, Shriver, C D, Ponniah, S, Peoples, GE

    Published in Oncology reports (01-03-2007)
    “…We used the Luminex assay to compare serum cytokine profiles of breast cancer patients (BCa) to healthy controls, node-positive (NP) patients to node-negative…”
    Get full text
    Journal Article
  9. 9

    Further characterization of the autoantibody response of Palmerston North mice by HANDWERGER, B. S, STORRER, C. E, WASSON, C. S, MOVAFAGH, F, REICHLIN, N. M

    Published in Journal of clinical immunology (1999)
    “…PN mice spontaneously develop, with age, a lupus-like disease. The present study further evaluated autoantibody production in female PN mice. As early as 1…”
    Get full text
    Journal Article
  10. 10

    Vasculitis in the Palmerston North mouse model of lupus: Phenotype and cytokine production profile of infiltrating cells by Luzina, Irina G., Knitzer, Robert H., Atamas, Sergei P., Gause, William C., Papadimitriou, John C., Sztein, Marcelo B., Storrer, Catherine E., Handwerger, Barry S.

    Published in Arthritis and rheumatism (01-03-1999)
    “…Objective To define the phenotype of cells in the perivascular and vascular infiltrates of Palmerston North (PN) mice and the cytokines that those cells…”
    Get full text
    Journal Article